BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 5802834)

  • 1. The regression of Ehrlich's ascites tumour cells transplanted intraperitoneally in rats.
    Hardy D
    Arch Immunol Ther Exp (Warsz); 1969; 17(3):372-5. PubMed ID: 5802834
    [No Abstract]   [Full Text] [Related]  

  • 2. Dynamics of growth and regression of Ehrlich ascites carcinoma transplanted intraperitoneally in rats.
    Janik P; Dabrowski M; Dux K
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):717-23. PubMed ID: 5957993
    [No Abstract]   [Full Text] [Related]  

  • 3. Hematologic changes in rats inoculated intraperitoneally with Ehrlich ascites carcinoma.
    Dabrowska B; Janik P; Radwański Z; Dux K
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):724-9. PubMed ID: 5957994
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative study of Ehrlich's ascites tumor transplanted in mice and rats with the aid of an electronic counter].
    Desaive C
    Bull Cancer; 1969; 56(3):321-30. PubMed ID: 5403283
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of ionizing radiations on some immunological phenomena in Ehrlich's ascites tumor].
    Juliani G; Piccotti F; Isoardi Pons A
    Minerva Radiol; 1966; 11(1):74-7. PubMed ID: 5909345
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative investigation of the effect of ukrain on growth of ascites and solid forms of Ehrlich's carcinoma.
    Susak YM; Skivka LM; Rudik MP; Pozur VV; Liubunya AV
    Exp Oncol; 2010 Jul; 32(2):107-10. PubMed ID: 20693973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in the immunobiologic properties of Ehrlich ascites carcinoma under the effect of suspension from normal rat tissues. I. Heterotransplantation of Ehrlich ascites carcinoma].
    Novikov DK
    Tsitologiia; 1965; 7(3):420-3. PubMed ID: 5879870
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of the immunologic status of the host on the percentage of polyploid cells in Ehrlich's ascites tumor].
    Dux K; Czarnomska A; Bregula U
    Nowotwory; 1973; 23(1):7-13. PubMed ID: 4715450
    [No Abstract]   [Full Text] [Related]  

  • 9. [On sensitivity to sarcolysine of Ehrlich's ascites tumors in mice "vaccinated" with treated tumor cells from animals previously treated with sarcolysine alone or with other antineoplastic drugs (thioguanine, actinomycin D)].
    Bonmassar E; Melan F; Testorelli C
    Arch Ital Patol Clin Tumori; 1968; 11(1):229-44. PubMed ID: 5745130
    [No Abstract]   [Full Text] [Related]  

  • 10. [Radiotherapy and immunological phenomena in the evolution of Ehrlich's tumor].
    Juliani G; Piccotti F; Cirillo R
    Radiol Med; 1968 Jun; 54(6):556-73. PubMed ID: 5201412
    [No Abstract]   [Full Text] [Related]  

  • 11. Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.
    Valadares MC; Ramos AL; Rehmann FJ; Sweeney NJ; Strohfeldt K; Tacke M; Queiroz ML
    Eur J Pharmacol; 2006 Mar; 534(1-3):264-70. PubMed ID: 16513106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antineoplastic immunological reactions in animals with Ehrlich's carcinoma].
    Bergamini G; D'Acunzo L; Fazio G; Giudici G
    Riv Patol Clin Sper; 1967; 8(4):477-88. PubMed ID: 5605966
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tween 80 and immunological defense against Ehrlich's ascitic carcinoma].
    Castagnone Prati D; Di Roberto F; Ingrami A
    Arch Ital Patol Clin Tumori; 1967; 10(1):29-35. PubMed ID: 5600139
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of splenectomy on the regression of transplantable tumors.
    Ferrer JF; Mihich E
    Cancer Res; 1968 Jun; 28(6):1116-20. PubMed ID: 5658442
    [No Abstract]   [Full Text] [Related]  

  • 15. Resistance and susceptibility to tumours. IV. The temporary survival and rejection of the Ehrlich ascites carcinoma in xenogeneic hosts.
    Dvorák R; Karásek J
    Neoplasma; 1970; 17(4):361-71. PubMed ID: 4394171
    [No Abstract]   [Full Text] [Related]  

  • 16. Resistance to Ehrlich ascites tumor in a strain of dystrophic mice.
    Carry PJ; Prescott DM; Ogilvie GK
    Cancer Res; 1979 Jun; 39(6 Pt 1):2139-40. PubMed ID: 445411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological changes in BFU hairless mice injected by homologous tumours -- Ehrlich's and Brno carcinomas.
    Dvoŕák R; Chlumecký J; Bĕlar A
    Scr Med (Brno); 1965; 38(6):285-94. PubMed ID: 5849734
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the cell cycle of Ehrlich carcinoma cells transplanted into allogeneic and xenogeneic hosts.
    Janik P
    Arch Immunol Ther Exp (Warsz); 1969; 17(5):590-6. PubMed ID: 5370177
    [No Abstract]   [Full Text] [Related]  

  • 19. [Resistance to Ehrlich's ascites carcinoma in mice immunized with killed tumor cells].
    D'Alessandro G; Giammanco G; Barncato P
    Riv Ist Sieroter Ital; 1967; 42(6):332-49. PubMed ID: 5601777
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of P32 in ionic form on the cells of Ehrlich's ascites tumor].
    Piccotti F; Cirillo R; Ferrero B; Ballaira L
    Cancro; 1967; 20(3):303-22. PubMed ID: 5605377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.